Join AlphaMaven

The Home Of Alternative Investments

Register For Free Learn More Create Investment Listing

Most Visited Alternative Investment Industry Website. Over 50,000 visitors per month

Alternative Investment Posts

Fast 50 Extra-Large No. 1: Pax8 Sees Triple-Digit Growth As It Goes Global - October 21, 2021
Private Equity Sageview Capital LP Views: 1

Pax8 is no stranger to Denver Business Journal’s awards programs. From Best Places to Work to the C-Suite Awards and right here in the Fast 50 where they took the first place spot in 2020, the company’s rapid growth, big acquisitions and global expansion are proving that major success can be found in the cloud. The Greenwood Village-based company is clocking in with 549% growth rate this year in the Extra-large category.

You’ve been on quite the acquisitio


Member Posts:

Most popular| Most recent
Golden Eagle Growth Fund - AlphaMaven Performance Report
3h ago Hedge Fund Golden Eagle Hypergrowth Strategy #Investment Update
Volt Program (QEP) - AlphaMaven Performance Report
3h ago Managed Futures Volt Program (QEP) #Investment Update
G2 Investment Partners LP - AlphaMaven Performance Report
3h ago Hedge Fund G2 Investment Partners LP #Investment Update
Gates Capital Management's ECF Value Fund - AlphaMaven Performance Report
3h ago Hedge Fund ECF Value Fund, L.P. #Investment Update
Campbell Market-Neutral Quantitative Equities Portfolio - AlphaMaven Performance Report
3h ago Hedge Fund Campbell Market-Neutral Quantitative Equities Portfolio - Global #Investment Update
Cooper Creek Partners (Class A) - AlphaMaven Performance Report
3h ago Hedge Fund Cooper Creek Partners LLC (Class A) #Investment Update
Shannon River, LP - AlphaMaven Performance Report
3h ago Hedge Fund Shannon River, LP #Investment Update
Soaring Pelican Blended Advantage Investment Strategy - AlphaMaven Performance Report
3h ago Managed Futures Blended Advantage Investment Strategy #Investment Update
HGI Real Estate Securities Fund - AlphaMaven Performance Report
3h ago Hedge Fund HGI Real Estate Securities Fund #Investment Update
Crescent Bay Capital Management - Conservative Growth Index Program - AlphaMaven Perfo ...
3h ago Managed Futures Crescent Bay Capital Management- Conservative Growth Index Program #Investment Update
Crescent Bay Capital Management - Fixed Premium Managed Program - AlphaMaven Performan ...
3h ago Managed Futures Crescent Bay Capital Management- Fixed Premium Managed Program #Investment Update
Crescent Bay Capital Management - Premium Alpha Managed Program - AlphaMaven Performan ...
3h ago Managed Futures Crescent Bay Capital Management- Premium Alpha Managed Program #Investment Update
Le Mans Trading Hyperion Fund - AlphaMaven Performance Report
3h ago Managed Futures Hyperion Fund #Investment Update
G2 Long Only Fund QP LP - AlphaMaven Performance Report
3h ago Hedge Fund G2 Long Only Fund QP LP #Investment Update
Campbell Absolute Return Portfolio - AlphaMaven Performance Report
3h ago Hedge Fund Campbell Absolute Return Portfolio #Investment Update
Campbell Core Trend With Dynamic Risk Targeting Portfolio (DRT) - AlphaMaven Performan ...
3h ago Managed Futures Campbell Core Trend With Dynamic Risk Targeting Portfolio (DRT) #Investment Update
Campbell Core Trend - Dynamic Risk Targeting Portfolio Correlation Capped (DRTCC) - Al ...
3h ago Managed Futures Campbell Core Trend - Dynamic Risk Targeting Portfolio Correlation Capped (DRTCC) #Investment Update
Campbell Managed Futures Portfolio - AlphaMaven Performance Report
3h ago Managed Futures Campbell Managed Futures Portfolio #Investment Update
SDI Basic Partner Fund - AlphaMaven Performance Report
3h ago Hedge Fund Basic Partner Fund #Investment Update
SDI Partners - Accredited Partner Fund - AlphaMaven Performance Report
3h ago Hedge Fund SDI Partners - Accredited Partner Fund #Investment Update
CREATE A FREE MEMBERSHIP
View Member Posts Listings
SPONSORED BY
Be Seen - Advertise With Us
Click to Discuss
FEATURED MEMBER POSTS
Andrea Alms Video:  Money In Motion 145 - Biotech IPO Market Forecast 2025
- posted by: BrookDell Partners
Andrea Alms Video:  Money In Motion 146 - Migraine Drug Market
- posted by: BrookDell Partners
Andrea Alms Video:  Money In Motion 142 - 2025 Whitehouse Stops All Communication With HHS, FDA, CDC
- posted by: BrookDell Partners
Andrea Alms Video:  Money In Motion 143 - 2024 Cancer Research Breakthroughs
- posted by: BrookDell Partners
Andrea Alms Video:  Money In Motion 144 -The Bird Flu Market
- posted by: BrookDell Partners
Andrea Alms Video:  Money In Motion 147 - Pediatric Healthcare Market
- posted by: BrookDell Partners
Andrea Alms Video: Money In Motion 148 - Water Market
- posted by: BrookDell Partners
Log In for More
Access Over 250K+ Industry Headlines, Posts and Updates

Subscribe to our FREE DAILY newsletter

Please Select Industry Primary Role*
Not a member yet?

Join AlphaMaven

The Premier Alternative Investment
Research and Due Diligence Platform for Investors

Free Membership for Qualified Investors and Industry Participants
  • Easily Customize Content to Match Your Investment Preferences
  • Breaking News 24/7/365
  • Daily Newsletter & Indices
  • Alternative Investment Listings & LeaderBoards
  • Industry Research, Due Diligence, Videos, Webinars, Events, Press Releases, Market Commentary, Newsletters, Fact Sheets, Presentations, Investment Mandates, Video PitchBooks & More!
  • Company Directory
  • Contact Directory
  • Member Posts & Publications
  • Alpha University Video Series to Expand Investor Knowledge
  • AUM Accelerator Program (designed for investment managers)
  • Over 450K+ Industry Headlines, Posts and Updates
Sign Up Now
ALL ALPHAMAVEN CONTENT IS FOR INFORMATIONAL PURPOSES ONLY. CONTENT POSTED BY MEMBERS DOES NOT NECESSARILY REFLECT THE OPINION OR BELIEFS OF ALPHAMAVEN AND HAS NOT ALWAYS BEEN INDEPENDENTLY VERIFIED BY ALPHAMAVEN. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. THIS IS NOT A SOLICITATION FOR INVESTMENT. THE MATERIAL PROVIDED HEREIN IS FOR INFORMATIONAL PURPOSES ONLY. IT DOES NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO BUY ANY INTERESTS OF ANY FUND OR ANY OTHER SECURITIES. ANY SUCH OFFERINGS CAN BE MADE ONLY IN ACCORDANCE WITH THE TERMS AND CONDITIONS SET FORTH IN THE INVESTMENT'S PRIVATE PLACEMENT MEMORANDUM. PRIOR TO INVESTING, INVESTORS ARE STRONGLY URGED TO REVIEW CAREFULLY THE PRIVATE PLACEMENT MEMORANDUM (INCLUDING THE RISK FACTORS DESCRIBED THEREIN), THE LIMITED PARTNERSHIP AGREEMENT AND THE SUBSCRIPTION DOCUMENTS, TO ASK SUCH QUESTIONS OF THE INVESTMENT MANAGER AS THEY DEEM APPROPRIATE, AND TO DISCUSS ANY PROSPECTIVE INVESTMENT IN THE FUND WITH THEIR LEGAL AND TAX ADVISERS IN ORDER TO MAKE AN INDEPENDENT DETERMINATION OF THE SUITABILITY AND CONSEQUENCES OF AN INVESTMENT.